Inflammation markers help predict breast cancer survival

05/27/2009 | Boston Globe (tiered subscription model), The

U.S. researchers found breast cancer patients with high levels of C-reactive protein and serum amyloid A, both markers for inflammation, were two to three times more likely to die early or have a recurrence of the disease. Testing for these markers could help determine a woman's prognosis, they said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC